Luciferase reportor driven by c-erbB2
Clone info. | Luciferase reportor driven by c-erbB2. Please refer Fig.2 of Maeda, T., Cancer Gene Ther. 8 (11): 890-896, 2001 for construction. |
---|---|
Comment | Cloned fragment: 39699972 to 39700098(NC_000017.11); relatively -6 to +121, where +1 corresponds to 1 nt of NM_004448.3. |
Vector backbone | pGL2-basic (Plasmid) |
Selectable markers | Amp^r |
Gene/insert name | Human c-erbB2/erb-B Genomic DNA |
Depositor|Developer | Tagawa, Masatoshi | |
Additional map | ![]() |
---|
Please check terms and conditions set forth by the depositor, which are specified in the RIKEN BRC Catalog and/or Web Catalog.
Ordering forms | Order form [Credit Card Payment ![]() ![]() ![]() MTA, for use for not-for-profit academic purpose [Word ![]() ![]() Please visit Information of Request for Distribution.[link] |
---|---|
Terms and conditions for distribution | In publishing the research results obtained by use of the BIOLOGICAL RESOURCE, a citation of literature designated by the DEPOSITOR is requested (Maeda, T., Cancer Gene Ther. 8 (11): 890-896, 2001). Additional terms and conditions: The use of the BIOLOGICAL RESOURCE is restricted to the academic researches conducted by non-profit organization. By using this material, the RECIPIENT agrees to be bound by the conditions of the limited use statement of the Promega Corporation. |
必要書類 | 提供依頼書 ![]() ![]() 提供同意書 (MTA, 非営利学術目的用)[Word ![]() ![]() 手続きの概要は、「提供申込みについて[link]」をご覧ください。 |
---|---|
MTAに書く使用条件 | 利用者は、研究成果の公表にあたって寄託者の指定する文献を引用する (Maeda, T., Cancer Gene Ther. 8 (11): 890-896, 2001)。 MTAに書く付加的使用条件: 本件リソースの使用は学術機関での学術研究に限る。本件リソースの使用にあたって、利用者はプロメガ社の限定使用条件に従う必要がある。 |
Catalog # | Resource name | Availability | Shipping form | Fee (non-profit org.) |
---|---|---|---|---|
RDB02842 | c-erbB2 promoter(124)-pGL2-basic | Under QC test. Please contact us. | DNA solution |
JPY 9,460 (not-for-profit academic purpose) plus cost of shipping containers, dry ice (if required) and shipping charge |
Materials & Methods section:
The c-erbB2 promoter(124)-pGL2-basic was provided by the RIKEN BRC through the National BioResource Project of the MEXT, Japan (cat. RDB02842). |
Reference section:
Maeda, T., O-Wang, J., Matsubara, H., Asano, T., Ochiai, T., Sakiyama, S., Tagawa, M., A minimum c-erbB-2 promoter-mediated expression of herpes simplex virus thymidine kinase gene confers selective cytotoxicity of human breast cancer cells to ganciclovir. Cancer Gene Ther. 8 (11): 890-896 (2001). PMID 11773979. [link to RRC of NBRP] |
Further references such as user reports and related articles (go to bottom)
Please wait for results of QC test to be uploaded. This clone will be sequenced a portion for examination.
Original, user report and related articles
original | Maeda, T., A minimum c-erbB-2 promoter-mediated expression of herpes simplex virus thymidine kinase gene confers selective cytotoxicity of human breast cancer cells to ganciclovir. Cancer Gene Ther. 8 (11): 890-896 (2001). PMID 11773979. [link to RRC of NBRP] |
---|
Featured content